Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.9B |
| 2 |
Boeing
BA
|
+$956M |
| 3 |
Netflix
NFLX
|
+$804M |
| 4 |
EOG Resources
EOG
|
+$761M |
| 5 |
Wells Fargo
WFC
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.3B |
| 2 |
Nike
NKE
|
+$1.17B |
| 3 |
AbbVie
ABBV
|
+$1.16B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$987M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
ASML
ASML
$695B
| $12.8M | ﹤0.01% |
43,363
+905
| +2% | +$244K |
|
377
Public Storage
PSA
$60.4B
| $12.8M | ﹤0.01% |
60,109
+59
| +0.1% | +$13.1K |
|
378
Okta
OKTA
$25.6B
| $12.6M | ﹤0.01% |
109,063
| – | – |
|
379
Datadog
DDOG
$86.5B
| $11.7M | ﹤0.01% |
310,981
-1,039,019
| -77% | -$37.4M |
|
|
COUP
380
DELISTED
Coupa Software Incorporated
COUP
| $11.6M | ﹤0.01% |
79,500
-343,620
| -81% | -$49.1M |
|
381
PagerDuty
PD
$876M
| $9.36M | ﹤0.01% |
400,000
| – | – |
|
|
MDLA
382
DELISTED
Medallia, Inc.
MDLA
| $9.33M | ﹤0.01% |
300,000
| – | – |
|
|
ZEN
383
DELISTED
ZENDESK INC
ZEN
| $8.37M | ﹤0.01% |
109,279
-5,557,942
| -98% | -$407M |
|
384
Iron Mountain
IRM
$37B
| $8.15M | ﹤0.01% |
255,879
-492,454
| -66% | -$16.1M |
|
385
NMI Holdings
NMIH
$3.38B
| $7.57M | ﹤0.01% |
228,075
| – | – |
|
386
Walt Disney
DIS
$178B
| $7.45M | ﹤0.01% |
51,512
+46
| +0.1% | +$6.42K |
|
387
Health Catalyst
HCAT
$135M
| $6.81M | ﹤0.01% |
196,200
-26,900
| -12% | -$890K |
|
|
TACO
388
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $4.74M | ﹤0.01% |
600,000
-1,931,000
| -76% | -$15.6M |
|
389
Neuronetics
STIM
$223M
| $3.81M | ﹤0.01% |
847,721
-842,322
| -50% | -$5.23M |
|
390
Cactus
WHD
$5.8B
| $3.64M | ﹤0.01% |
+106,000
| New | +$3.22M |
|
|
TLND
391
DELISTED
Talend S.A. American Depositary Shares
TLND
| $3.19M | ﹤0.01% |
81,500
| – | – |
|
392
Ares Management
ARES
$32.1B
| $1.63M | ﹤0.01% |
45,670
+28,870
| +172% | +$897K |
|
|
NVCN
393
DELISTED
Neovasc Inc.
NVCN
| $1.34M | ﹤0.01% |
9,884
| – | – |
|
394
Sony
SONY
$138B
| $1.04M | ﹤0.01% |
76,885
+22,505
| +41% | +$281K |
|
|
CMLS
395
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $592K | ﹤0.01% |
33,691
| – | – |
|
396
Takeda Pharmaceutical
TAK
$55.6B
| $492K | ﹤0.01% |
25,046
+5,490
| +28% | +$105K |
|
397
ArcelorMittal
MT
$55.9B
| $349K | ﹤0.01% |
19,947
+4,506
| +29% | +$73K |
|
398
Rio Tinto
RIO
$165B
| $259K | ﹤0.01% |
4,378
+849
| +24% | +$46.1K |
|
399
Fresenius Medical Care
FMS
$12.6B
| $209K | ﹤0.01% |
5,683
+1,281
| +29% | +$45.4K |
|
400
Banco Santander
SAN
$211B
| $196K | ﹤0.01% |
49,626
+11,177
| +29% | +$43.4K |
|
Similar funds
Capital Research Global Investors's Q4 2019 Portfolio in Review
As of Q4 2019, Capital Research Global Investors held 433 positions worth $333B, up 9.4% from $305B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2019 filing shows 19 new, 239 increased, 105 reduced and 28 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M. The largest sale was Fidelity National Information Services, an estimated $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M.
- Capital Research Global Investors added most to UnitedHealth in Q4 2019, an estimated $1.9B increase.
- Capital Research Global Investors's biggest Q4 2019 reduction was Fidelity National Information Services, cutting an estimated $1.3B.
- Capital Research Global Investors fully exited 3M in Q4 2019, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $333B portfolio in Q4 2019.
- Capital Research Global Investors opened 19 new positions and closed 28 in Q4 2019.
- Capital Research Global Investors's portfolio value rose 9.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.